Laboratory Corporation of America Holdings

NYSE:LH

Market Cap

USD 21.81 B

Share Price

USD 260.59

Avg Daily Volume

809,447

Change (1 day)

1.41%

Change (1 year)

27.18%

Change (YTD)

13.64%

Laboratory Corporation of America Holdings Operating Income Margin for the Trailing 12 Months (TTM) ending March 31, 2025: 8.37%

Laboratory Corporation of America Holdings Operating Income Margin is 8.37% for the Trailing 12 Months (TTM) ending March 31, 2025, a -4.38% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.
  • Laboratory Corporation of America Holdings Operating Income Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was 8.75%, a -24.49% change year over year.
  • Laboratory Corporation of America Holdings Operating Income Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was 11.59%, a -36.38% change year over year.
  • Laboratory Corporation of America Holdings Operating Income Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 18.22%, a -24.49% change year over year.
  • Laboratory Corporation of America Holdings Operating Income Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was 24.13%, a 241.24% change year over year.
Key data
Date Operating Income Margin Gross Profit Margin EBIT Margin EBITDA Margin
Market news
Loading...
NYSE: LH

Laboratory Corporation of America Holdings

CEO Mr. Adam H. Schechter
IPO Date March 29, 1990
Location United States
Headquarters 358 South Main Street
Employees 60,900
Sector 🏥 Health Care
Industries
Description

Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations and accountable care organizations. It offers end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. Laboratory Corporation of America Holdings has a collaboration agreement with Tigerlily Foundation to increase clinical trial diversity for women of color. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.

Similar companies

BSX

Boston Scientific Corporation

USD 106.53

1.86%

SHL.DE

Siemens Healthineers AG

USD 54.95

0.27%

GEHC

GE HealthCare Technologies Inc.

USD 74.38

-0.64%

NTRA

Natera, Inc.

USD 167.96

-0.12%

BAX

Baxter International Inc.

USD 30.39

-0.36%

TORNTPHARM.NS

Torrent Pharmaceuticals Limited

USD 39.09

3.96%

ICLR

ICON Public Limited Company

USD 144.56

-1.49%

RGC

Regencell Bioscience Holdings Limited

USD 17.40

-13.82%

ASND

Ascendis Pharma A/S

USD 172.22

-0.42%

EXAS

Exact Sciences Corporation

USD 53.65

3.55%

CTEC.L

ConvaTec Group Plc

USD 3.97

0.08%

GH

Guardant Health, Inc.

USD 50.86

1.66%

300832.SZ

Shenzhen New Industries Biomedical Engineering Co., Ltd.

USD 7.80

-2.41%

DIA.MI

DiaSorin S.p.A.

USD 107.84

-1.95%

688617.SS

APT Medical Inc.

USD 41.29

1.54%

3347.HK

Hangzhou Tigermed Consulting Co., Ltd.

USD 4.54

-0.29%

LNTH

Lantheus Holdings, Inc.

USD 81.49

0.93%

TMDX

TransMedics Group, Inc.

USD 131.45

1.07%

ADMA

ADMA Biologics, Inc.

USD 18.16

-1.30%

LAURUSLABS.NS

Laurus Labs Limited

USD 8.21

3.42%

IPCALAB.NS

Ipca Laboratories Limited

USD 15.58

-0.70%

INSP

Inspire Medical Systems, Inc.

USD 132.41

2.08%

600566.SS

Hubei Jumpcan Pharmaceutical Co., Ltd.

USD 4.04

2.01%

002603.SZ

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

USD 1.95

-0.21%

PFIZER.NS

Pfizer Limited

USD 66.66

0.62%

300676.SZ

BGI Genomics Co., Ltd.

USD 6.85

-0.11%

ERIS.NS

Eris Lifesciences Limited

USD 19.60

3.84%

LIVN

LivaNova PLC

USD 45.75

-0.11%

300529.SZ

Jafron Biomedical Co.,Ltd.

USD 2.97

-0.59%

VIMIAN.ST

Vimian Group AB (publ)

USD 4.15

0.75%

VCYT

Veracyte, Inc.

USD 27.38

2.13%

BAVA.CO

Bavarian Nordic A/S

USD 26.54

-0.57%

0853.HK

MicroPort Scientific Corporation

USD 1.10

-0.01%

VITR.ST

Vitrolife AB (publ)

USD 14.82

2.00%

QDEL

QuidelOrtho Corporation

USD 28.87

0.59%

NVCR

NovoCure Limited

USD 18.00

5.26%

603882.SS

Guangzhou Kingmed Diagnostics Group Co., Ltd.

USD 4.02

2.05%

CERT

Certara, Inc.

USD 11.38

-0.35%

ADPT

Adaptive Biotechnologies Corporation

USD 11.79

-3.04%

HRMY

Harmony Biosciences Holdings, Inc.

USD 31.98

0.38%

ARQT

Arcutis Biotherapeutics, Inc.

USD 13.74

-4.58%

002287.SZ

Tibet Cheezheng Tibetan Medicine Co., Ltd.

USD 3.13

0.29%

688289.SS

Sansure Biotech Inc.

USD 2.83

0.22%

INDGN.NS

Indegene Limited

USD 6.65

-0.83%

603567.SS

Heilongjiang ZBD Pharmaceutical Co., Ltd.

USD 1.65

-0.57%

002020.SZ

Zhejiang Jingxin Pharmaceutical Co., Ltd.

USD 1.80

0.01%

300026.SZ

Tianjin Chase Sun Pharmaceutical Co.,Ltd

USD 0.51

0.20%

605507.SS

Guobang Pharma Ltd.

USD 2.75

0.23%

688016.SS

Shanghai MicroPort Endovascular MedTech Co., Ltd.

USD 12.19

-0.25%

BHVN

Biohaven Ltd.

USD 14.09

-4.41%

StockViz Staff

June 30, 2025

Any question? Send us an email